Answers are grounded in this paper and cite their sources.
The results of treating a series of 105 patients (79 with advanced squamous cell carcinoma, 21 with advanced lymphoma, and 5 with miscellaneous tumours) with bleomycin are described. The drug was usually given as a single agent. Four patients with squamous cell carcinoma showed complete regression and there was partial regression in 25. Side effects were frequent, particularly skin changes and stomatitis; death from pneumonitis occurred in one patient.
No takes yet. Share an insight, caveat, or question.
Halnan et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: